Evaluation of Glass Ionomer Cement Modified With Chlorhexidine and Titanium Dioxide in Primary Molars (RCT)
Launched by AIN SHAMS UNIVERSITY · Dec 1, 2022
Trial Information
Current as of January 16, 2025
Completed
Keywords
ClinConnect Summary
The study will be a randomized clinical trial, with a 1:1:1 allocation ratio and parallel arms that will enroll children from the outpatient clinic of pediatric dentistry department, Ain shams University Blinding: Enrolled children, assessors and statistician will be blinded. Randomization: block randomization with blocks of 6. A maximum of 2 primary molars per patient will receive the same treatment.
Allocation concealment: Allocation will be done just before placement of a restoration to avoid performance bias during the cavity preparation. The envelope will be only checked after cavity ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The teeth will be primary molars selected from patients presented to the outpatient clinic that are
- • Healthy patients.
- • Children having at least one primary molar with only occlusal caries having dentine lesions (ADA caries classification system mostly 1 or 2 please check)
- • Dentine caries must be apparent visually or radiographically
- Exclusion Criteria:
- • .Teeth with pulp involvement, those suffering from pain, irreversible pulpits or pulp necrosis.
- • Patients with history of active para-functional oral habits, xerostomia.
- • Patients who will have difficulties in cooperating
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials